Fractionated intravesical radioimmunotherapy with (213)Bi-anti-EGFR-MAb is effective without toxic side-effects in a nude mouse model of advanced human bladder carcinoma

Gold standard in therapy of superficial, non-muscle invasive urothelial tumors is transurethral resection followed by intravesical instillation therapies. However, relapse is commonly observed and therefore new therapeutic approaches are needed. Application of (213)Bi-immunoconjugates targeting EGFR...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Biol Ther
Päätekijät: Fazel, Julia, Rötzer, Silvia, Seidl, Christof, Feuerecker, Benedikt, Autenrieth, Michael, Weirich, Gregor, Bruchertseifer, Frank, Morgenstern, Alfred, Senekowitsch-Schmidtke, Reingard
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Taylor & Francis 2015
Aiheet:
Research Papers
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4846129/
https://ncbi.nlm.nih.gov/pubmed/26177233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2015.1071735
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia